![](/img/cover-not-exists.png)
PSS10 Cost- Effectiveness of Ranibizumab in Patients with Neovascular Wet Age-Related Macular Degeneration (Namd) at the Mexican Social Security System (Imss)
Arreola-Ornelas, H., Rosado-Buzzo, A., García-Mollinedo, L., Dorantes-Aguilar, J., Lemus-Carmona, E.Volume:
15
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2012.03.1354
Date:
June, 2012
File:
PDF, 59 KB
english, 2012